All Stories

  1. Clinical aPDT's effect on Candida albicans: Antifungal susceptibility, virulence gene expression, and correlation with leukocyte and neutrophil counts
  2. Green Synthesis of Au-Doped Tin Oxide Nanoparticles Using Teucrium Polium Extract with Potential Applications in Photodynamic Therapy
  3. What is the potential of antibacterial, antiviral and antifungal photodynamic therapy in dentistry?
  4. A structural and biochemical approach to effect of temperature and pH on the Molten Globule phenomenon in a thermophilic protease: Molecular dynamics simulation, fluorescence spectroscopy and circular dichroism
  5. Proteases, a powerful biochemical tool in the service of medicine, clinical and pharmaceutical
  6. Assessing the Effects of Curcumin and 450 nm Photodynamic Therapy on Oxidative Metabolism and Cell Cycle in Head and Neck Squamous Cell Carcinoma: An In Vitro Study
  7. Photobiomodulation preconditioned diabetic adipose derived stem cells with additional photobiomodulation: an additive approach for enhanced wound healing in diabetic rats with a delayed healing wound
  8. Use of the traditional Chinese medicine “compound healthy ear agent” to protect against age-related hearing loss in mice: A proteomics study
  9. Histological evaluation of monopolar and bipolar radiofrequency microneedling treatment in a porcine model
  10. Comparison of 755‐nm picosecond alexandrite laser versus 1064‐nm Q‐switched Nd:YAG laser for melasma: A randomized, split‐face controlled, 2‐year follow‐up study
  11. Photobiomodulation therapy (red/NIR LEDs) reduced the length of stay in intensive care unit and improved muscle function: A randomized, triple‐blind, and sham‐controlled trial
  12. In-silico characterization of a thermophilic serine protease via homology modeling, docking and molecular dynamics simulations
  13. Transcranial photobiomodulation mitigates learning and memory impairments induced by hindlimb unloading in a mouse model of microgravity exposure by suppression of oxidative stress and neuroinflammation signaling pathways
  14. A Phase 1 randomized, open‐label clinical trial to evaluate the effect of a far‐infrared emitting patch on local skin perfusion, microcirculation and oxygenation
  15. Recent advances in 3D bioprinted tumor models for personalized medicine
  16. Microbial Phytases: Properties and Applications in the Food Industry
  17. Phenylalanine-Arginine-β-Naphthylamide Enhances the Photobactericidal Effect of Methylene Blue on Pseudomonas aeruginosa
  18. Transcranial photobiomodulation for the brain: a wide range of clinical applications
  19. Mechanism and antibacterial synergies of poly(Dabco-BBAC) against multi-drug resistant Pseudomonas aeruginosa isolates from human burns
  20. Dose and time–response effect of photobiomodulation therapy on glycemic control in type 2 diabetic patients combined or not with hypoglycemic medicine: A randomized, crossover, double‐blind, sham‐controlled trial
  21. Combined Use of Photobiomodulation and Curcumin-Loaded Iron Oxide Nanoparticles Significantly Improved Wound Healing in Diabetic Rats Compared to Either Treatment Alone
  22. Photobiomodulation, alone or combined with adipose-derived stem cells, reduces inflammation by modulation of microRNA-146a and interleukin-1ß in a delayed-healing infected wound in diabetic rats
  23. Photobiomodulation Therapy for Muscular Dystrophy: Time for a Trial?
  24. Fiat Lux: Light and Pedagogy for the 21st Century
  25. Apoptosis and myocardial infarction: role of ncRNAs and exosomal ncRNAs
  26. Insights into Photobiomodulation and Oxidative Stress: Physiological, Pathological, and Therapeutic Impact
  27. Factors associated with treatment failure, and possible applications of probiotic bacteria in the arsenal against Helicobacter pylori
  28. Photobiomodulation for Skin Pigmentation Disorders: A Dual-Function Treatment
  29. In silico design and immunoinformatics analysis of a chimeric vaccine construct based on Salmonella pathogenesis factors
  30. Could Photobiomodulation Be Incorporated into Indoor Lighting?
  31. Mitochondrial Transplantation: Could Photobiomodulation Play a Role?
  32. Could Photobiomodulation Therapy Be Helpful in Epilepsy?
  33. Role of opsins and light or heat activated transient receptor potential ion channels in the mechanisms of photobiomodulation and infrared therapy.
  34. Photobiomodulation Therapy for Treatment of Extravasation Injuries in Cancer Chemotherapy
  35. Role of Polarized Light in Photobiomodulation
  36. Do Biophotons Play Any Role in Transcranial Photobiomodulation of the Brain?
  37. Correlations between single nucleotide polymorphisms in obsessive-compulsive disorder with the clinical features or response to therapy
  38. Applications of resveratrol in the treatment of gastrointestinal cancer
  39. Traditional or Infrared Saunas and Photobiomodulation: What Do They Have in Common?
  40. Saponin and fluorine-modified polycation as a versatile gene delivery system
  41. Aspects of Antiviral Strategies Based on Different Phototherapy Approaches: Hit by the Light
  42. Phototherapy-Based Treatment for Sexually Transmitted Infections—Shining Light into Unexplored Territory
  43. Optimization of the Duration and Dose of Photobiomodulation Therapy (660 nm Laser) for Spinal Cord Injury in Rats
  44. Photobiomodulation for Gulf War Illness?
  45. Macrophage Cell Membrane‐Cloaked Nanoplatforms for Biomedical Applications
  46. Lysophosphatidic Acid Signaling and microRNAs: New Roles in Various Cancers
  47. Hyaluronic Acid-Based Nanomaterials as a New Approach to the Treatment and Prevention of Bacterial Infections
  48. MicroRNAs and Synaptic Plasticity: From Their Molecular Roles to Response to Therapy
  49. Could Photobiomodulation Treat Autism Spectrum Disorder?
  50. Nanoscale bioconjugates: A review of the structural attributes of drug-loaded nanocarrier conjugates for selective cancer therapy
  51. Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy
  52. Physical properties and biological effects of ceramic materials emitting infrared radiation for pain, muscular activity, and musculoskeletal conditions
  53. An update on Becker's nevus: Pathogenesis and treatment
  54. The potential of curcumin for treating spinal cord injury: a meta-analysis study
  55. Effects of microRNAs and long non-coding RNAs on chemotherapy response in glioma
  56. Neuronal differentiation potential of primary and immortalized adipose stem cells by photobiomodulation
  57. Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator?
  58. Injection of Cerium Oxide Nanoparticles to Treat Spinal Cord Injury in Rats
  59. Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity
  60. Safety of 222 nm UVC Irradiation to the Surgical Site in a Rabbit Model
  61. Application of Quercetin in the Treatment of Gastrointestinal Cancers
  62. Role of the Bone Marrow Microenvironment in Drug Resistance of Hematological Malignances
  63. Photobiomodulation and Stem Cell on Repair of Osteoporotic Bones
  64. Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy
  65. Nanomaterials for photothermal and photodynamic cancer therapy
  66. Non-coding RNAs and glioblastoma: Insight into their roles in metastasis
  67. Rapid monitoring of serum albumin as a biomarker of liver and kidney diseases using femtosecond laser-induced fluorescence
  68. Histidine‐enhanced gene delivery systems: The state of the art
  69. Platinum Nanoparticles in Biomedicine: Preparation, Anti-Cancer Activity, and Drug Delivery Vehicles
  70. Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies
  71. MicroRNA let-7 and viral infections: focus on mechanisms of action
  72. Antibacterial, antibiofilm, anti-inflammatory, and wound healing effects of nanoscale multifunctional cationic alternating copolymers
  73. Photobiomodulation Therapy Mechanisms Beyond Cytochrome c Oxidase
  74. Comprehensive analysis of ceRNA networks to determine genes related to prognosis, overall survival, and immune infiltration in clear cell renal carcinoma
  75. RdRp inhibitors and COVID-19: Is molnupiravir a good option?
  76. Smart Strategies for Precise Delivery of CRISPR/Cas9 in Genome Editing
  77. Non-Coding RNAs and Brain Tumors: Insights Into Their Roles in Apoptosis
  78. Potential of natural products in the treatment of myocardial infarction: focus on molecular mechanisms
  79. Cell cycle involvement in cancer therapy; WEE1 kinase, a potential target as therapeutic strategy
  80. Gold nanostructures: synthesis, properties, and neurological applications
  81. Targeting the metabolism of cancer stem cells by energy disruptor molecules
  82. Physiological, biochemical, and metabolic responses of abiotic plant stress: salinity and drought
  83. Photodynamic therapy for squamous cell carcinoma of the head and neck: narrative review focusing on photosensitizers
  84. 3D bioprinting technology to mimic the tumor microenvironment: tumor-on-a-chip concept
  85. The role of non-coding RNAs in chemotherapy for gastrointestinal cancers
  86. Improved wound healing of diabetic foot ulcers using human placenta-derived mesenchymal stem cells in gelatin electrospun nanofibrous scaffolds plus a platelet-rich plasma gel: A randomized clinical trial
  87. MicroRNA-155 and antiviral immune responses
  88. Potential of natural products in osteosarcoma treatment: Focus on molecular mechanisms
  89. The effect of photobiomodulation therapy on antioxidants and oxidative stress profiles of adipose derived mesenchymal stem cells in diabetic rats
  90. Smart arginine-equipped polycationic nanoparticles for p/CRISPR delivery into cells
  91. Cellulose-Based Nanofibril Composite Materials as a New Approach to Fight Bacterial Infections
  92. Beneficial effects of infrared light-emitting diode in corticosteroid-resistant asthma
  93. Polylysine for skin regeneration: A review of recent advances and future perspectives
  94. Local (but not systemic) photobiomodulation treatment reduces mast cell degranulation, eicosanoids, and Th2 cytokines in an experimental model of allergic rhinitis
  95. Polyethylenimine-Functionalized Carbon Dots for Delivery of CRISPR/Cas9 Complexes
  96. Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression
  97. Editorial: Antimicrobial Photodynamic Therapy: A New Paradigm in the Fight Against Infections
  98. The potential application of organoids in breast cancer research and treatment
  99. Review of Oxygenation with Nanobubbles: Possible Treatment for Hypoxic COVID-19 Patients
  100. Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects
  101. Photobiomodulation Enhances Memory Processing in Older Adults with Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy Study
  102. Photobiomodulation Therapy for Dementia: A Systematic Review of Pre-Clinical and Clinical Studies
  103. Pilot Study on Dose-Dependent Effects of Transcranial Photobiomodulation on Brain Electrical Oscillations: A Potential Therapeutic Target in Alzheimer’s Disease
  104. Photobiomodulation of the Brain: Shining Light on Alzheimer’s and Other Neuropathological Diseases
  105. Coumarins and Gastrointestinal Cancer: A New Therapeutic Option?
  106. Applications of scaffold-based advanced materials in biomedical sensing
  107. Carbon Nanotubes: Smart Drug/Gene Delivery Carriers [Corrigendum]
  108. COVID-19 in patients with cancer: Risks and precautions
  109. Diagnostic and drug release systems based on microneedle arrays in breast cancer therapy
  110. Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer
  111. Roles of Non-coding RNAs and Angiogenesis in Glioblastoma
  112. Distribution of gold nanoparticles into the brain: a systematic review and meta-analysis
  113. Electroconductive multi-functional polypyrrole composites for biomedical applications
  114. Long Noncoding RNAs CAT2064 and CAT2042 may Function as Diagnostic Biomarkers for Prostate Cancer by Affecting Target MicrorRNAs
  115. Comprehensive review on ultrasound-responsive theranostic nanomaterials: mechanisms, structures and medical applications
  116. Alginate scaffolds improve functional recovery after spinal cord injury
  117. Effect of Celliant® armbands on grip strength in subjects with chronic wrist and elbow pain: randomized double-blind placebo-controlled trial
  118. Emerging role of nanoclays in cancer research, diagnosis, and therapy
  119. Radiolabeled carbon-based nanostructures: New radiopharmaceuticals for cancer therapy?
  120. A randomized, controlled, split‐face study of topical timolol maleate 0.5% eye drops for the treatment of erythematotelangiectatic rosacea
  121. Bioinspired hydrogels build a bridge from bench to bedside
  122. Dysregulated expression of miRNAs in immune thrombocytopenia
  123. Functionalized magnetic nanoparticles for the separation and purification of proteins and peptides
  124. Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies
  125. The effect of femtosecond laser irradiation on the growth kinetics of Staphylococcus aureus: An in vitro study
  126. Neurotoxicity of silver nanoparticles in the animal brain: a systematic review and meta-analysis
  127. Hybrid Bionanocomposite Containing Magnesium Hydroxide Nanoparticles Embedded in a Carboxymethyl Cellulose Hydrogel Plus Silk Fibroin as a Scaffold for Wound Dressing Applications
  128. Development of neoantigens: from identification in cancer cells to application in cancer vaccines
  129. Advanced Bioresponsive Multitasking Hydrogels in the New Era of Biomedicine
  130. Interplay between SOX9 transcription factor and microRNAs in cancer
  131. Photoneuromodulation makes a difficult cognitive task less arduous
  132. Plant-based vaccines and cancer therapy: Where are we now and where are we going?
  133. Turning Toxic Nanomaterials into a Safe and Bioactive Nanocarrier for Co-delivery of DOX/pCRISPR
  134. Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead
  135. Angiogenesis-related non-coding RNAs and gastrointestinal cancer
  136. Cell death pathways and viruses: Role of microRNAs
  137. Antimicrobial photodynamic therapy for oral Candida infection in adult AIDS patients: A pilot clinical trial
  138. Green chemistry and coronavirus
  139. Long non-coding RNAs in the doxorubicin resistance of cancer cells
  140. Non-coding RNAs related to angiogenesis in gynecological cancer
  141. Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems
  142. The role of SOX family transcription factors in gastric cancer
  143. Transcranial photobiomodulation prevents PTSD-like comorbidities in rats experiencing underwater trauma
  144. Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy
  145. Digital Transformation of Photobiomodulation Therapy: A Step Forward to Become Mainstream?
  146. Effect of Transcranial Low-Level Light Therapy Among Patients With Moderate Traumatic Brain Injury
  147. Recent advances and challenges of RT-PCR tests for the diagnosis of COVID-19
  148. Low‐dose photodynamic therapy effect on closure of scratch wounds of normal and diabetic fibroblast cells: An in vitro study
  149. Immune checkpoint inhibition in classical hodgkin lymphoma
  150. Photobiomodulation prevents PTSD-like memory impairments in rats
  151. Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers
  152. Streptococcal bacterial components in cancer therapy
  153. Chitosan-Based Nanoparticles Against Viral Infections
  154. Effects of the phenotypic polarization state of human leukocytes on the optical absorbance spectrum
  155. A preliminary clinical trial comparing wet silver dressings versus wet‐to‐dry povidone‐iodine dressings for wound healing in pemphigus vulgaris patients
  156. Use of Salmonella Bacteria in Cancer Therapy: Direct, Drug Delivery and Combination Approaches
  157. Carbon Nanotubes: Smart Drug/Gene Delivery Carriers
  158. The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators
  159. Mechanistic aspects of photobiomodulation therapy in the nervous system
  160. Ki-67 expression as a diagnostic biomarker in odontogenic cysts and tumors: A systematic review and meta-analysis
  161. Infrared radiation from cage bedding moderates rat inflammatory and autoimmune responses in collagen-induced arthritis
  162. Applications of advanced materials in bio-sensing in live cells: Methods and applications
  163. Crosstalk between long non-coding RNA DLX6-AS1, microRNAs and signaling pathways: A pivotal molecular mechanism in human cancers
  164. Development of a graphene oxide-poly lactide nanocomposite as a Smart Drug Delivery System
  165. Electrospraying as a novel method of particle engineering for drug delivery vehicles
  166. Transcranial Photobiomodulation to Improve Cognition in Gulf War Illness
  167. The Photosensitizing Efficacy of Micelles Containing a Porphyrinic Photosensitizer and KI against Resistant Melanoma Cells
  168. The Influence of Some Axial Ligands on Ruthenium–Phthalocyanine Complexes: Chemical, Photochemical, and Photobiological Properties
  169. Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance
  170. Effects of therapeutic probiotics on modulation of microRNAs
  171. Approaches for the integration of big data in translational medicine: single‐cell and computational methods
  172. The colorful world of carotenoids: a profound insight on therapeutics and recent trends in nano delivery systems
  173. Interdisciplinary Approaches to COVID-19
  174. Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles
  175. Probable positive effects of the photobiomodulation as an adjunctive treatment in COVID-19: A systematic review
  176. Organic dots (O-dots) for theranostic applications: preparation and surface engineering
  177. Corrigendum to ‘5-Aza-2’-deoxycytidine potentiates antitumor immune response induced by photodynamic therapy’ [the Eur J Canc (2014) 1370–1381]
  178. Autoantigen-specific immune tolerance in pathological and physiological cell death: Nanotechnology comes into view
  179. Bispecific monoclonal antibodies for targeted immunotherapy of solid tumors: Recent advances and clinical trials
  180. Molecular beacon strategies for sensing purpose
  181. Photobiomodulation and Antiviral Photodynamic Therapy in COVID-19 Management
  182. Photodynamic therapy accelerates skin wound healing through promoting re-epithelialization
  183. The Toxic Effect of Silver Nanoparticles on Nerve Cells: A Systematic Review and Meta-Analysis
  184. Two long non-coding RNAs, CAT179 and CAT 1796, differentiate between benign prostate hyperplasia and prostate cancer
  185. Factors Affecting Photodynamic Therapy and Anti-Tumor Immune Response
  186. Exosomes and Lung Cancer: Roles in Pathophysiology, Diagnosis and Therapeutic Applications
  187. Comparison of Fractional Micro‐Plasma Radiofrequency and Fractional Microneedle Radiofrequency for the Treatment of Atrophic Acne Scars: A Pilot Randomized Split‐Face Clinical Study in China
  188. Innate lymphoid cell subsets and their cytokines in autoimmune diseases
  189. Multivalent nanomedicines to treat COVID-19: A slow train coming
  190. Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials
  191. Regulation of Glycolysis by Non-coding RNAs in Cancer: Switching on the Warburg Effect
  192. The effect of chondroitinase ABC and photobiomodulation therapy on neuropathic pain after spinal cord injury in adult male rats
  193. Polymeric Nanoparticles for Nasal Drug Delivery to the Brain: Relevance to Alzheimer's Disease
  194. The potential use of theranostic bacteria in cancer
  195. Recent progress in the design of DNA vaccines against tuberculosis
  196. Light-based technologies for management of COVID-19 pandemic crisis
  197. The therapeutic potential of resveratrol in a mouse model of melanoma lung metastasis
  198. Tumor cryotherapy using Ice-producing bacteria
  199. PIWI-interacting RNAs and PIWI proteins in glioma: molecular pathogenesis and role as biomarkers
  200. Nano-based delivery systems for berberine: A modern anti-cancer herbal medicine
  201. Carbosilane dendrimers: Drug and gene delivery applications
  202. Photobiomodulation for spinal cord injury: A systematic review and meta-analysis
  203. Stimulus-responsive sequential release systems for drug and gene delivery
  204. Metal‐based nanoparticles for bone tissue engineering
  205. Effect of Transcranial Low-Level Light Therapy vs Sham Therapy Among Patients With Moderate Traumatic Brain Injury
  206. Exosomal microRNAs derived from mesenchymal stem cells: cell-to-cell messages
  207. Potential Applications of Advanced Nano/Hydrogels in Biomedicine: Static, Dynamic, Multi‐Stage, and Bioinspired
  208. Autophagy-related MicroRNAs in chronic lung diseases and lung cancer
  209. Recent Developments in Graphene and Graphene Oxide: Properties, Synthesis, and Modifications: A Review
  210. COVID-19: Transmission, prevention, and potential therapeutic opportunities
  211. Combined therapy of adipose-derived stem cells and photobiomodulation on accelerated bone healing of a critical size defect in an osteoporotic rat model
  212. Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality
  213. Nanomicellar-curcumin exerts its therapeutic effects via affecting angiogenesis, apoptosis, and T cells in a mouse model of melanoma lung metastasis
  214. Non-coding RNAs and Exosomes: Their Role in the Pathogenesis of Sepsis
  215. Quantity does not equal quality: Scientific principles cannot be sacrificed
  216. The immune system and COVID-19: Friend or foe?
  217. The Use of Fluorescent Probes to Detect ROS in Photodynamic Therapy
  218. Mesenchymal Stem Cell Spheroids Embedded in an Injectable Thermosensitive Hydrogel: An In Situ Drug Formation Platform for Accelerated Wound Healing
  219. Cytokines and COVID-19: friends or foes?
  220. A Novel Treatment of Opioid Cravings With an Effect Size of .73 for Unilateral Transcranial Photobiomodulation Over Sham
  221. Transdermal delivery of topical lidocaine in a mouse model is enhanced by treatment with cold atmospheric plasma
  222. A randomized split‐face, investigator‐blinded study of a picosecond Alexandrite laser for post‐inflammatory erythema and acne scars
  223. Role of exosomes in malignant glioma: microRNAs and proteins in pathogenesis and diagnosis
  224. Nanovehicles for co-delivery of anticancer agents
  225. Circular RNAs: New Epigenetic Signatures in Viral Infections
  226. Corrigendum: Photobiomodulation preconditioning prevents cognitive impairment in a neonatal rat model of hypoxia‐ischemia
  227. Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways
  228. Applications of cold atmospheric plasma for transdermal drug delivery: a review
  229. Photobiomodulation for Alzheimer’s Disease: Translating Basic Research to Clinical Application
  230. Photobiomodulation‐Induced Differentiation of Immortalized Adipose Stem Cells to Neuronal Cells
  231. Autophagy in cancers including brain tumors: role of MicroRNAs
  232. TGF-β and WNT signaling pathways in cardiac fibrosis: non-coding RNAs come into focus
  233. Corrigendum to “Potassium iodide enhances the photobactericidal effect of methylene blue on Enterococcus faecalis as planktonic cells and as biofilm infection in teeth” [J Photochem Photobiol B 203(2020) 1–11/111730]
  234. Bioresorbable composite polymeric materials for tissue engineering applications
  235. The urgent need for integrated science to fight COVID-19 pandemic and beyond
  236. A powerful combination of copper-cysteamine nanoparticles with potassium iodide for bacterial destruction
  237. Controlled Gene Delivery Systems: Nanomaterials and Chemical Approaches
  238. Recent advances in nanotechnology-based drug delivery systems for the kidney
  239. Therapeutic potential of intranasal photobiomodulation therapy for neurological and neuropsychiatric disorders: a narrative review
  240. Photobiomodulation for Parkinson’s Disease in Animal Models: A Systematic Review
  241. Successful treatment of polymorphic light eruption with UVA rush hardening: A report of 5 cases
  242. MicroRNAs and exosomes: key players in HIV pathogenesis
  243. Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells
  244. Fluorescent light energy in wound healing: when is a photon something more?
  245. Interactions Between Tumor Biology and Targeted Nanoplatforms for Imaging Applications
  246. Comparison of DNA and mRNA vaccines against cancer
  247. Combined effects of metformin and photobiomodulation improve the proliferation phase of wound healing in type 2 diabetic rats
  248. Exosomal miRNAs: novel players in viral infection
  249. Increased Functional Connectivity Within Intrinsic Neural Networks in Chronic Stroke Following Treatment with Red/Near-Infrared Transcranial Photobiomodulation: Case Series with Improved Naming in Aphasia
  250. Need for Caution When Applying Photobiomodulation Therapy for Hereditary Diseases
  251. Recent advances in porphyrin-based nanocomposites for effective targeted imaging and therapy
  252. Recent advances in the application of mesoporous silica-based nanomaterials for bone tissue engineering
  253. Oxygen-Independent Antimicrobial Photoinactivation: Type III Photochemical Mechanism?
  254. Hyaluronic acid‐decorated liposomal nanoparticles for targeted delivery of 5‐fluorouracil into HT‐29 colorectal cancer cells
  255. Photobiomodulation plus Adipose-derived Stem Cells Improve Healing of Ischemic Infected Wounds in Type 2 Diabetic Rats
  256. Photodynamic Therapy for Cancer: What's Past is Prologue
  257. Efficient photodynamic inactivation of Candida albicans by porphyrin and potassium iodide co-encapsulation in micelles
  258. Enhanced activity of vancomycin by encapsulation in hybrid magnetic nanoparticles conjugated to a cell-penetrating peptide
  259. Nanotechnology for angiogenesis: opportunities and challenges
  260. A Microneedling Fractional Radiofrequency Device for the Treatment of Nevus Comedonicus
  261. Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role
  262. Drug efflux pumps in photodynamic therapy
  263. PAMAM Dendrimers as a Delivery System for Small Interfering RNA
  264. Potassium iodide enhances the photobactericidal effect of methylene blue on Enterococcus faecalis as planktonic cells and as biofilm infection in teeth
  265. Photobiomodulation therapy for management of inferior alveolar nerve injury post-extraction of impacted lower third molars
  266. Theranostic applications of stimulus-responsive systems based on carbon dots
  267. Bioengineering International joins the Family of Platinum Open Access Journals
  268. Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis?
  269. Microfluidic devices with gold thin film channels for chemical and biomedical applications: a review
  270. miRNAs derived from cancer-associated fibroblasts in colorectal cancer
  271. “Photobiomics”: Can Light, Including Photobiomodulation, Alter the Microbiome?
  272. Pathogenic role of exosomes and microRNAs in HPV‐mediated inflammation and cervical cancer: A review
  273. Exploration of Copper-Cysteamine Nanoparticles as a New Type of Agents for Antimicrobial Photodynamic Inactivation
  274. Penetration Profiles of Visible and Near-Infrared Lasers and Light-Emitting Diode Light Through the Head Tissues in Animal and Human Species: A Review of Literature
  275. Potential Application of Upconverting Nanoparticles for Brain Photobiomodulation
  276. Reported Side Effects, Weight and Blood Pressure, After Repeated Sessions of Transcranial Photobiomodulation
  277. Transcranial Photobiomodulation Improves Cognitive Performance in Young Healthy Adults: A Systematic Review and Meta-Analysis
  278. Transcranial Photobiomodulation with Near-Infrared Light for Generalized Anxiety Disorder: A Pilot Study
  279. Differentiation of Mesenchymal Stem Cells to Neuroglia: in the Context of Cell Signalling
  280. Photobiomodulation for the management of alopecia: mechanisms of action, patient selection and perspectives
  281. Tetracyclines: light-activated antibiotics?
  282. CFIm25 and alternative polyadenylation: Conflicting roles in cancer
  283. In vitro photodynamic therapy of endothelial cells using hematoporphyrin monomethyl ether (Hemoporfin): Relevance to treatment of port wine stains
  284. Photobiomodulation combined with photodynamic therapy using ruthenium phthalocyanine complexes in A375 melanoma cells: Effects of nitric oxide generation and ATP production
  285. The effects of photodynamic therapy with blue light and papain-based gel associated with Urucum, on collagen and fibroblasts: a spectroscopic and cytotoxicity analysis
  286. Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders
  287. Multimodal quantitative imaging of brain cancer in cultured cells
  288. Photobiomodulation for Alzheimer’s Disease: Has the Light Dawned?
  289. Microfluidic Brain-on-a-Chip: Perspectives for Mimicking Neural System Disorders
  290. Stimulus-responsive polymeric nanogels as smart drug delivery systems
  291. Carbon based nanomaterials for tissue engineering of bone: Building new bone on small black scaffolds: A review
  292. Applications of Photobiomodulation Therapy to Musculoskeletal Disorders and Osteoarthritis with Particular Relevance to Canada
  293. How to Write a Good Photobiomodulation Article
  294. Photodynamic therapy for cancer: Role of natural products
  295. S198. Effects of Transcranial Photobiomodulation With Near-Infrared Light on Sexual Dysfunction
  296. F85. Reported Side-Effects, Weight and Blood Pressure After Repeated Sessions of Transcranial Photobiomodulation
  297. Amphiphilic tetracationic porphyrins are exceptionally active antimicrobial photosensitizers: In vitro and in vivo studies with the free‐base and Pd‐chelate
  298. Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities
  299. Advances in detection of fastidious bacteria: From microscopic observation to molecular biosensors
  300. Biomedical applications of nanoflares: Targeted intracellular fluorescence probes
  301. Photobiomodulation and Coenzyme Q10 Treatments Attenuate Cognitive Impairment Associated With Model of Transient Global Brain Ischemia in Artificially Aged Mice
  302. Rapid Reversal of Cognitive Decline, Olfactory Dysfunction, and Quality of Life Using Multi-Modality Photobiomodulation Therapy: Case Report
  303. Photobiomodulation preconditioning prevents cognitive impairment in a neonatal rat model of hypoxia‐ischemia
  304. Selective photobiomodulation for emotion regulation: model-based dosimetry study
  305. Fluorescence Polarization of Methylene Blue as a Quantitative Marker of Breast Cancer at the Cellular Level
  306. Corrigendum
  307. Effective treatment and decolonization of a dog infected with carbapenemase ( VIM ‐2)‐producing Pseudomonas aeruginosa using probiotic and photodynamic therapies
  308. Introduction to “Advances in Photodynamic Therapy 2018”
  309. A combination of photodynamic therapy and antimicrobial compounds to treat skin and mucosal infections: a systematic review
  310. Sodium nitrite potentiates antimicrobial photodynamic inactivation: possible involvement of peroxynitrate
  311. Under the spotlight: mechanisms of photobiomodulation concentrating on blue and green light
  312. Near-infrared photobiomodulation combined with coenzyme Q10 for depression in a mouse model of restraint stress: reduction in oxidative stress, neuroinflammation, and apoptosis
  313. Design, synthesis and photobiological activity of novel ruthenium phthalocyanine complexes
  314. Correction: Photobiomodulation: lasers vs. light emitting diodes?
  315. Correction to: Photobiomodulation with single and combination laser wavelengths on bone marrow mesenchymal stem cells: proliferation and differentiation to bone or cartilage
  316. Review of light parameters and photobiomodulation efficacy: dive into complexity
  317. Photobiomodulation improves the frontal cognitive function of older adults
  318. Novel pharmacotherapy for burn wounds: what are the advancements
  319. Inorganic Salts and Antimicrobial Photodynamic Therapy: Mechanistic Conundrums?
  320. Photodynamic therapy for rosacea in Chinese patients
  321. Surface treatment with non-thermal humid argon plasma as a treatment for allergic contact dermatitis in a mouse model
  322. Transcranial Photobiomodulation for the Treatment of Major Depressive Disorder. The ELATED-2 Pilot Trial
  323. Antimicrobial Photodynamic Inactivation Mediated by Tetracyclines in Vitro and in Vivo: Photochemical Mechanisms and Potentiation by Potassium Iodide
  324. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities
  325. Early diagnosis of disease using microbead array technology: A review
  326. Effect of red light and near infrared laser on the generation of reactive oxygen species in primary dermal fibroblasts
  327. A preliminary study of fractional CO2 laser added to topical tacrolimus combined with 308 nm excimer lamp for refractory vitiligo
  328. Point-of-care microfluidic devices for pathogen detection
  329. Mitochondrial dynamics (fission and fusion) and collagen production in a rat model of diabetic wound healing treated by photobiomodulation: comparison of 904 nm laser and 850 nm light-emitting diode (LED)
  330. Photobiomodulation with single and combination laser wavelengths on bone marrow mesenchymal stem cells: proliferation and differentiation to bone or cartilage
  331. Effects of transcranial photobiomodulation with near-infrared light on sexual dysfunction
  332. Mouse model of Gram-negative prosthetic joint infection reveals therapeutic targets
  333. PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy
  334. Attaching NorA efflux pump inhibitors to methylene blue enhances antimicrobial photodynamic inactivation of Escherichia coli and Acinetobacter baumannii in vitro and in vivo
  335. Comparison of two functionalized fullerenes for antimicrobial photodynamic inactivation: Potentiation by potassium iodide and photochemical mechanisms
  336. Multiplexed microarrays based on optically encoded microbeads
  337. Comparison of thiocyanate and selenocyanate for potentiation of antimicrobial photodynamic therapy
  338. Can light-based approaches overcome antimicrobial resistance?
  339. Photobiomodulation, Photomedicine, and Laser Surgery: A New Leap Forward Into the Light for the 21st Century
  340. Non-mammalian Hosts and Photobiomodulation: Do All Life-forms Respond to Light?
  341. Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
  342. Targeting the mitochondrial VDAC in hepatocellular carcinoma using a polyclonal antibody-conjugated to a nitrosyl ruthenium complex
  343. Bacterial components as naturally inspired nano-carriers for drug/gene delivery and immunization: Set the bugs to work?
  344. Antimicrobial Photodynamic Therapy to Control Clinically Relevant Biofilm Infections
  345. Can 3D imaging provide insights into spatial variations in bacterial infection patterns?
  346. Pain management using photobiomodulation: Mechanisms, location, and repeatability quantified by pain threshold and neural biomarkers in mice
  347. Tetracyclines function as dual-action light-activated antibiotics
  348. Antimicrobial photodynamic therapy mediated by methylene blue and potassium iodide to treat urinary tract infection in a female rat model
  349. Antimicrobial photodynamic inactivation is potentiated by the addition of selenocyanate: Possible involvement of selenocyanogen?
  350. Flexible quantum dot light-emitting devices for targeted photomedical applications
  351. Current and Future Trends in Adipose Stem Cell Differentiation into Neuroglia
  352. Corrigendum to “Disinfection and healing effects of 222-nm UVC light on methicillin-resistant Staphylococcus aureus infection in mouse wounds” [J. Photochem. Photobiol. B Biol. 178 (January 2018) 10–18]
  353. Outstanding Reviewers for Photochemical and Photobiological Sciences in 2017
  354. Photobiomodulation and Cancer: What Is the Truth?
  355. Treatment of atrophic acne scarring with fractional micro-plasma radio-frequency in Chinese patients: A prospective study
  356. Options and Limitations in Clinical Investigation of Bacterial Biofilms
  357. Construction and response of a highly granular scintillator-based electromagnetic calorimeter
  358. 1012 Examining Daytime Sleepiness, Sleep Apnea, and Cognitive Decline in a 2-year Longitudinal Sample of Cognitively Normal Elderly
  359. Remodeling of dermal collagen in photoaged skin using low-dose 5-aminolevulinic acid photodynamic therapy occurs via the transforming growth factor-β pathway
  360. Potentiation by potassium iodide using TPPS4 for antimicrobial photodynamic inactivation
  361. Transcranial near-infrared photobiomodulation attenuates memory impairment and hippocampal oxidative stress in sleep-deprived mice
  362. 5-Aminolevulinic acid photodynamic therapy in refractory vulvar lichen sclerosus et atrophicus: Series of ten cases
  363. End of life care and nursing satisfaction is enhanced by the implementation of a clinical information system based protocol
  364. Noble metal nanostructures in optical biosensors: Basics, and their introduction to anti-doping detection
  365. Aging of lymphoid organs: Can photobiomodulation reverse age‐associated thymic involution via stimulation of extrapineal melatonin synthesis and bone marrow stem cells?
  366. Potassium iodide potentiates antimicrobial photodynamic inactivation mediated by Rose Bengal: in vitro and in vivo studies
  367. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation
  368. Brain Photobiomodulation Therapy: a Narrative Review
  369. Optical assays based on colloidal inorganic nanoparticles
  370. Potentiation by potassium iodide reveals that the anionic porphyrin TPPS4 is a surprisingly effective photosensitizer for antimicrobial photodynamic inactivation
  371. Fullerenes as photosensitizers in photodynamic therapy: pros and cons
  372. Photobiomodulation: lasersvs.light emitting diodes?
  373. Progressive cationic functionalization of chlorin derivatives for antimicrobial photodynamic inactivation and related vancomycin conjugates
  374. Upconversion in photodynamic therapy: plumbing the depths
  375. Introduction
  376. Advances in nature-inspired nanomaterials
  377. Alopecia
  378. Aptamers and pathogen-based carriers
  379. Carbon-based nanomaterials
  380. Disinfection and healing effects of 222-nm UVC light on methicillin-resistant Staphylococcus aureus infection in mouse wounds
  381. Drug delivery approaches
  382. Nanomedicine and advanced technologies for burns: Preventing infection and facilitating wound healing
  383. Polymeric and hyper-branched nanoparticles and dendrimers
  384. Reply to the Letter to the Editor on “Effects of Light-Emitting Diode Therapy on Muscle Hypertrophy, Gene Expression, Performance, Damage, and Delayed-Onset Muscle Soreness
  385. Noninvasive optical and nuclear imaging of Staphylococcus-specific infection with a human monoclonal antibody-based probe
  386. Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications
  387. Methylene Blue and Hydrogen Peroxide for Photodynamic Inactivation in Root Canal - A New Protocol for Use in Endodontics
  388. Photobiomodulation for traumatic brain injury and stroke
  389. Antimicrobial blue light inactivation of pathogenic microbes: State of the art
  390. Potentiation of antimicrobial photodynamic inactivation by inorganic salts
  391. NLRP3 Inflammasome Mediates Dormant Neutrophil Recruitment following Sterile Lung Injury and Protects against Subsequent Bacterial Pneumonia in Mice
  392. Can regenerative medicine and nanotechnology combine to heal wounds? The search for the ideal wound dressing
  393. In-vivo monitoring of infectious diseases in living animals using bioluminescence imaging
  394. Development of a Click Beetle Luciferase Reporter System for Enhanced Bioluminescence Imaging of Listeria monocytogenes: Analysis in Cell Culture and Murine Infection Models
  395. Carbon nanotubes in microfluidic lab-on-a-chip technology: current trends and future perspectives
  396. Photodynamic therapy in dermatology beyond non-melanoma cancer: An update
  397. Attaching the NorA Efflux Pump Inhibitor INF55 to Methylene Blue Enhances Antimicrobial Photodynamic Inactivation of Methicillin-Resistant Staphylococcus aureus in Vitro and in Vivo
  398. Red (660 nm) or near-infrared (810 nm) photobiomodulation stimulates, while blue (415 nm), green (540 nm) light inhibits proliferation in human adipose-derived stem cells
  399. Advances in antimicrobial photodynamic inactivation at the nanoscale
  400. Non-invasive three-dimensional imaging of Escherichia coli K1 infection using diffuse light imaging tomography combined with micro-computed tomography
  401. Significant Improvement in Cognition in Mild to Moderately Severe Dementia Cases Treated with Transcranial Plus Intranasal Photobiomodulation: Case Series Report
  402. Zinc phthalocyanines attached to gold nanorods for simultaneous hyperthermic and photodynamic therapies against melanoma in vitro
  403. Visible Blue Light is Capable of Inactivating Candida albicans and Other Fungal Species
  404. Photobiomodulation of breast and cervical cancer stem cells using low-intensity laser irradiation
  405. Photobiomodulation leads to enhanced radiosensitivity through induction of apoptosis and autophagy in human cervical cancer cells
  406. Biological effects and medical applications of infrared radiation
  407. 380. Transcranial Photobiomodulation for Brain Disorders
  408. 383. Transcranial plus Intranasal Photobiomodulation in Mild to Moderately-Severe Dementia
  409. <em>In Vivo</em> Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant <em>Acinetobacter baumannii</em> Burn Infections Using Bioluminescence Imaging
  410. Potassium Iodide Potentiates Antimicrobial Photodynamic Inactivation Mediated by Rose Bengal in In Vitro and In Vivo Studies
  411. Plant protein-based hydrophobic fine and ultrafine carrier particles in drug delivery systems
  412. Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL
  413. MP23-18 SYNERGISTIC PHOTODYNAMIC THERAPY FOR CATHETER-ASSOCIATED URINARY TRACT INFECTION IN RATS
  414. Type I and Type II Photosensitized Oxidation Reactions: Guidelines and Mechanistic Pathways
  415. Aus- und Weiterbildung
  416. Smart Nanostructures for Cargo Delivery: Uncaging and Activating by Light
  417. Management of Hypertension Using Olmesartan Alone or in Combination
  418. ROS generation and DNA damage with photo-inactivation mediated by silver nanoparticles in lung cancer cell line
  419. Mechanisms and Effects of Transcranial Direct Current Stimulation
  420. Quantum dot light emitting devices for photomedical applications
  421. Can microbial cells develop resistance to oxidative stress in antimicrobial photodynamic inactivation?
  422. Terahertz Spectroscopy to Determine Cold Shock Protein Stability Upon Solvation and Evaporation—A Molecular Dynamics Study
  423. Combinatory antibiotic therapy increases rate of bacterial kill but not final outcome in a novel mouse model of Staphylococcus aureus spinal implant infection
  424. Potassium Iodide Potentiates Broad-Spectrum Antimicrobial Photodynamic Inactivation Using Photofrin
  425. Infrared radiative properties and thermal modeling of ceramic-embedded textile fabrics
  426. Photobiomodulation of human adipose-derived stem cells using 810 nm and 980 nm lasers operates via different mechanisms of action
  427. Design features for optimization of tetrapyrrole macrocycles as antimicrobial and anticancer photosensitizers
  428. Photoantimicrobials—are we afraid of the light?
  429. Preclinical Evaluation of Photoacoustic Imaging as a Novel Noninvasive Approach to Detect an Orthopaedic Implant Infection
  430. Antimicrobial Blue Light Therapy for Infectious Keratitis: Ex Vivo and In Vivo Studies
  431. Surface-initiated polymerization with poly(n-hexylisocyanate) to covalently functionalize silica nanoparticles
  432. N-dihydrogalactochitosan as a potent immune activator for dendritic cells
  433. Noble metal nanoparticles in biosensors: recent studies and applications
  434. Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger
  435. Facial Manifestations of Pachydermoperiostosis Treated with Botulinum Toxin Type-A: Report of 3 Cases
  436. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation
  437. Photobiomodulation and Other Light Stimulation Procedures
  438. Photobiomodulation for Stroke
  439. Photomedicine and Stem Cells: The Janus face of photodynamic therapy (PDT) to kill cancer stem cells, and photobiomodulation (PBM) to stimulate normal stem cells
  440. Sonodynamic inactivation of Gram-positive and Gram-negative bacteria using a Rose Bengal–antimicrobial peptide conjugate
  441. Ultraviolet Irradiation of Blood: “The Cure That Time Forgot”?
  442. Photobiomodulation and the brain: a new paradigm
  443. Sodium ascorbate kills Candida albicans in vitro via iron-catalyzed Fenton reaction: importance of oxygenation and metabolism
  444. Photobiomodulation or low-level laser therapy
  445. Shining light on the head: Photobiomodulation for brain disorders
  446. Transcranial Low-Level Laser (Light) Therapy for Brain Injury
  447. Transcranial, Red/Near-Infrared Light-Emitting Diode Therapy to Improve Cognition in Chronic Traumatic Brain Injury
  448. Photobiomodulation in human muscle tissue: an advantage in sports performance?
  449. The application of antimicrobial photodynamic therapy (aPDT) in dentistry: a critical review
  450. Redox-Sensitive Smart Nanosystems for Drug and Gene Delivery
  451. Accelerated wound healing in a diabetic rat model using decellularized dermal matrix and human umbilical cord perivascular cells
  452. Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos
  453. Low-level laser therapy (904nm) can increase collagen and reduce oxidative and nitrosative stress in diabetic wounded mouse skin
  454. A Study of Physical and Mechanical Properties of the Indian Coconut for Efficient Dehusking
  455. Antimicrobial photodynamic inactivation: a bright new technique to kill resistant microbes
  456. Use of fluorescent probes for ROS to tease apart Type I and Type II photochemical pathways in photodynamic therapy
  457. Effects of Light-Emitting Diode Therapy on Muscle Hypertrophy, Gene Expression, Performance, Damage, and Delayed-Onset Muscle Soreness
  458. Surface-initiated ring-opening metathesis polymerization (SI-ROMP) to attach a tethered organic corona onto CdSe/ZnS core/shell quantum dots
  459. Photobiomodulation (blue and green light) encourages osteoblastic-differentiation of human adipose-derived stem cells: role of intracellular calcium and light-gated ion channels
  460. Papain gel containing methylene blue for simultaneous caries removal and antimicrobial photoinactivation against Streptococcus mutans biofilms
  461. Temperature-Responsive Smart Nanocarriers for Delivery Of Therapeutic Agents: Applications and Recent Advances
  462. Current Advances in 5-Aminolevulinic Acid Mediated Photodynamic Therapy
  463. Design, construction and commissioning of the Digital Hadron Calorimeter—DHCAL
  464. Light-emitting diode therapy in exercise-trained mice increases muscle performance, cytochrome c oxidase activity, ATP and cell proliferation [J. Biophotonics 8, No. 9, 740-754 (2015)]
  465. Broad-Spectrum Antimicrobial Effects of Photocatalysis Using Titanium Dioxide Nanoparticles Are Strongly Potentiated by Addition of Potassium Iodide
  466. The optical properties of mouse skin in the visible and near infrared spectral regions
  467. Virulence profile: Michael R. Hamblin
  468. Albumin nanostructures as advanced drug delivery systems
  469. Photodynamic therapy of oral Candida infection in a mouse model
  470. Broad-spectrum antimicrobial photocatalysis mediated by titanium dioxide and UVA is potentiated by addition of bromide ion via formation of hypobromite
  471. Low-level laser therapy stimulates the oxidative burst in human neutrophils and increases their fungicidal capacity
  472. DHCAL with minimal absorber: measurements with positrons
  473. Novel in vivo mouse model of implant related spine infection
  474. Structural and Kinetic Studies of Formate Dehydrogenase from Candida boidinii
  475. 274 A comparison of two new techniques for bacterial collection in cellulitis
  476. Malignant Glomus Tumor Arising in a Long Standing Precursor Lesion
  477. Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy
  478. That bloody so-and-so has retired: Expressives revisited
  479. The effect of low level laser therapy on ventilator-induced lung injury in mice (Conference Presentation)
  480. Ultraviolet blood irradiation: Is it time to remember “the cure that time forgot”?
  481. Errata: Transcranial low-level laser therapy (810 nm) temporarily inhibits peripheral nociception: photoneuromodulation of glutamate receptors, prostatic acid phophatase, and adenosine triphosphate
  482. Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols
  483. Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations
  484. Repeated transcranial low‐level laser therapy for traumatic brain injury in mice: biphasic dose response and long‐term treatment outcome
  485. Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis
  486. Application of Fluorescent Protein Expressing Strains to Evaluation of Anti-Tuberculosis Therapeutic Efficacy In Vitro and In Vivo
  487. Nanotechnology in diagnosis and treatment of coronary artery disease
  488. Antimicrobial blue light inactivation ofCandida albicans:In vitroandin vivostudies
  489. Endogenous Antimicrobial Photosensitization
  490. Antimicrobial Blue Light Inactivation of Gram-Negative Pathogens in Biofilms: In Vitro and In Vivo Studies
  491. New photosensitizers for photodynamic therapy
  492. The Effect of Protein Mass Modulation on Human Dihydrofolate Reductase
  493. Infrared and skin: Friend or foe
  494. Transcranial low-level laser therapy (810 nm) temporarily inhibits peripheral nociception: photoneuromodulation of glutamate receptors, prostatic acid phophatase, and adenosine triphosphate
  495. pH ‐Sensitive stimulus‐responsive nanocarriers for targeted delivery of therapeutic agents
  496. Smart mesoporous silica nanoparticles for controlled-release drug delivery
  497. Antibiotic resistance for viral infections
  498. Conclusions
  499. Introduction
  500. Chemical modifications
  501. Examples of the synthesis of monocationic and polycationic fullerene derivativess
  502. Fullerenes
  503. Fullerenes as photosensitizers
  504. General aspects of photodynamic inactivation of bacteria
  505. In Vivo Bioluminescence Imaging of Intratumoral Bacteria
  506. In vitro anti-cancer PDT with fullerenes
  507. In vitro antimicrobial PDT with fullerenes
  508. In vivo PDT for cancer
  509. In vivo antimicorbial PDT with fullerenes
  510. Introduction to Imaging in Dermatology
  511. Microfluidic systems for stem cell-based neural tissue engineering
  512. Nanotechnology and regenerative therapeutics in plastic surgery: The next frontier
  513. Photo-induced charge transfer
  514. Photodynamic Therapy with Hexa(sulfo-n-butyl)[60]Fullerene Against Sarcoma In Vitro and In Vivo
  515. Photodynamic therapy
  516. Photosensitizer forumlations for fullerene-mediated PDT
  517. Resonant Energy Transfer
  518. Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems
  519. Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
  520. Shower development of particles with momenta from 15 GeV to 150 GeV in the CALICE scintillator-tungsten hadronic calorimeter
  521. Photobiomodulation with 660-nm and 780-nm laser on activated J774 macrophage-like cells: Effect on M1 inflammatory markers
  522. Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
  523. Animal models for photodynamic therapy (PDT)
  524. Photodynamic Therapy with Water-Soluble Cationic Fullerene Derivatives
  525. Photoactivation of ROS Production In Situ Transiently Activates Cell Proliferation in Mouse Skin and in the Hair Follicle Stem Cell Niche Promoting Hair Growth and Wound Healing
  526. Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies
  527. Multi-Modal Imaging with a Toolbox of Influenza AReporter Viruses
  528. Development of a proton CT head scanner
  529. John Joseph Hamblin
  530. Eradication of multidrug-resistant pseudomonas biofilm with pulsed electric fields
  531. Testing hadronic interaction models using a highly granular silicon–tungsten calorimeter
  532. Traumatic Brain Injury: A Major Medical Problem That Could Be Treated Using Transcranial, Red/Near-Infrared LED Photobiomodulation
  533. The impact of macrophage-cancer cell interaction on the efficacy of photodynamic therapy
  534. Antimicrobial photodynamic inactivation in nanomedicine: small light strides against bad bugs
  535. RELATIONSHIP BETWEEN DRY MATTER AND RIPENING TIME IN 'HASS' AVOCADO
  536. Development of a Bioluminescent Nitroreductase Probe for Preclinical Imaging
  537. Antimicrobial Photosensitizers: Drug Discovery Under the Spotlight
  538. Targeted imaging of bacterial infections: advances, hurdles and hopes
  539. Bacterial Photodynamic Inactivation Mediated by Methylene Blue and Red Light Is Enhanced by Synergistic Effect of Potassium Iodide
  540. Stable Synthetic Bacteriochlorins: Potent Light-Activated Anti-Cancer Drugs
  541. Red/near-infrared light-emitting diode therapy for traumatic brain injury
  542. Antimicrobial blue light therapy forCandida albicansburn infection in mice
  543. Low-Level Light in Combination with Metabolic Modulators for Effective Therapy of Injured Brain
  544. Pion and proton showers in the CALICE scintillator-steel analogue hadron calorimeter
  545. Therapeutic Options and Emerging Alternatives for Multidrug Resistant Staphylococcal Infections
  546. Harnessing the Power of Light to Treat Staphylococcal Infections Focusing on MRSA
  547. Network of Remote and Local Protein Dynamics in Dihydrofolate Reductase Catalysis
  548. Strategies to potentiate immune response after photodynamic therapy
  549. Low level light in combination with metabolic modulators for effective therapy
  550. Transcranial low-level laser therapy increases memory, learning, neuroprogenitor cells, BDNF and synaptogenesis in mice with traumatic brain injury
  551. Low level laser (light) therapy and photobiomodulation: the path forward
  552. Low-level light therapy potentiates NPe6-mediated photodynamic therapy in a human osteosarcoma cell line via increased ATP
  553. Potentiation of antimicrobial photodynamic inactivation mediated by a cationic fullerene by added iodide: in vitro and in vivo studies
  554. Light-emitting diode therapy (LEDT) before matches prevents increase in creatine kinase with a light dose response in volleyball players
  555. Time response of increases in ATP and muscle resistance to fatigue after low-level laser (light) therapy (LLLT) in mice
  556. Antimicrobial photodynamic therapy in dentistry
  557. Nerve repair by light
  558. Low-level Laser Therapy to the Mouse Femur Enhances the Fungicidal Response of Neutrophils against Paracoccidioides brasiliensis
  559. Drug discovery for alopecia: gone today, hair tomorrow
  560. Antimicrobial photodynamic inactivation with decacationic functionalized fullerenes: Oxygen-independent photokilling in presence of azide and new mechanistic insights
  561. Carbon nanotubes part II: a remarkable carrier for drug and gene delivery
  562. Carbon nanotubes part I: preparation of a novel and versatile drug-delivery vehicle
  563. Muscular pre-conditioning using light-emitting diode therapy (LEDT) for high-intensity exercise: a randomized double-blind placebo-controlled trial with a single elite runner
  564. T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?
  565. Nanotechnology for photodynamic therapy: a perspective from the Laboratory of Dr. Michael R. Hamblin in the Wellman Center for Photomedicine at Massachusetts General Hospital and Harvard Medical School
  566. Introduction
  567. Biomolecule-sensitive nanocarriers
  568. Enzyme-responsive nanocarriers
  569. Skin Photoaging
  570. Dual/multi-stimuli-sensitive nanocarriers
  571. Future perspectives and the global drug delivery systems market
  572. Pulsed Electric Fields for Burn Wound Disinfection in a Murine Model
  573. Redox-responsive micro/nanocarriers
  574. pH-sensitive micro/nanocarriers
  575. Low-level Laser (Light) Therapy Increases Mitochondrial Membrane Potential and ATP Synthesis in C2C12 Myotubes with a Peak Response at 3-6 h
  576. Spirit 2: An NCRI Randomised Study Comparing Dasatinib with Imatinib in Patients with Newly Diagnosed CML
  577. Escherichia coli dihydrofolate reductase catalyzed proton and hydride transfers: Temporal order and the roles of Asp27 and Tyr100
  578. Stable synthetic mono-substituted cationic bacteriochlorins mediate selective broad-spectrum photoinactivation of drug-resistant pathogens at nanomolar concentrations
  579. Low-level laser irradiation promotes the proliferation and maturation of keratinocytes during epithelial wound repair
  580. Light-emitting diode therapy in exercise-trained mice increases muscle performance, cytochrome c oxidase activity, ATP and cell proliferation
  581. Photodynamic Therapy Combined with Terbinafine Against Chromoblastomycosis and the Effect of PDT on Fonsecaea monophora In Vitro
  582. Performance of the first prototype of the CALICE scintillator strip electromagnetic calorimeter
  583. Combined <em>In vivo</em> Optical and µCT Imaging to Monitor Infection, Inflammation, and Bone Anatomy in an Orthopaedic Implant Infection in Mice
  584. Transcranial low-level laser therapy enhances learning, memory, and neuroprogenitor cells after traumatic brain injury in mice
  585. Real-Time Bioluminescence Imaging of Mixed Mycobacterial Infections
  586. Pre-Conditioning with Low-Level Laser (Light) Therapy: Light before the Storm
  587. Low-level laser therapy for traumatic brain injury in mice increases brain derived neurotrophic factor (BDNF) and synaptogenesis
  588. Functionalized Fullerenes in Photodynamic Therapy
  589. Photodynamic Therapy: One Step Ahead with Self-Assembled Nanoparticles
  590. Protein motions and the activation of the CH bond catalyzed by dihydrofolate reductase
  591. Real-time evaluation of two light delivery systems for photodynamic disinfection of Candida albicans biofilm in curved root canals
  592. Treatment of patients with suspected brain tuberculoma before or without bacteriologic confirmation in endemic places: report of two cases
  593. Azithromycin inhibits nuclear factor‐κB activation during lung inflammation: an in vivo imaging study
  594. Building, testing and validating a set of home-made von Frey filaments: A precise, accurate and cost effective alternative for nociception assessment
  595. Theranostic tumor homing nanocarriers for the treatment of lung cancer
  596. α–Intercalated cells defend the urinary system from bacterial infection
  597. Significant Improvements in Cognitive Performance Post-Transcranial, Red/Near-Infrared Light-Emitting Diode Treatments in Chronic, Mild Traumatic Brain Injury: Open-Protocol Study
  598. Eradication of multidrug-resistant A. baumannii in burn wounds by antiseptic pulsed electric field
  599. AB0349 Significance of Positive Anti-Ccp Antibody and Development of Interstitial Lung Disease in Patients with and without Clinically Apparent Rheumatoid Arthritis
  600. Topical Antimicrobials for Burn Infections – An Update
  601. Photoactivation of Endogenous Latent Transforming Growth Factor–β1 Directs Dental Stem Cell Differentiation for Regeneration
  602. Low-Level Laser Therapy Effectively Prevents Secondary Brain Injury Induced by Immediate Early Responsive Gene X-1 Deficiency
  603. Transfusion of stored blood impairs host defenses against Gram‐negative pathogens in mice
  604. Opening Up the Optical Imaging Window Using Nano-Luciferin
  605. 5-Aza-2′-deoxycytidine potentiates antitumour immune response induced by photodynamic therapy
  606. Photodynamic therapy with decacationic [60]fullerene monoadducts: Effect of a light absorbing electron-donor antenna and micellar formulation
  607. Physical energy for drug delivery; poration, concentration and activation
  608. Photoactivated rose bengal functionalized chitosan nanoparticles produce antibacterial/biofilm activity and stabilize dentin-collagen
  609. Microbiota of Human Breast Tissue
  610. Photodynamic therapy improves the ultraviolet-irradiated hairless mice skin
  611. Structure–function relationships of Nile blue (EtNBS) derivatives as antimicrobial photosensitizers
  612. Photodynamic therapy for melanoma: efficacy and immunologic effects
  613. Low-level light therapy (LLLT) for cosmetics and dermatology
  614. Combination Prophylactic Therapy with Rifampin Increases Efficacy against an Experimental Staphylococcus epidermidis Subcutaneous Implant-Related Infection
  615. Antimicrobial photodynamic therapy with decacationic monoadducts and bisadducts of [70]fullerene: in vitro and in vivo studies
  616. Extension and Limits of the Network of Coupled Motions Correlated to Hydride Transfer in Dihydrofolate Reductase
  617. Efficacy and Safety of a Low-level Laser Device in the Treatment of Male and Female Pattern Hair Loss: A Multicenter, Randomized, Sham Device-controlled, Double-blind Study
  618. Combination ALA-PDT and ablative fractional Er:YAG laser (2,940 nm) on the treatment of severe acne
  619. Potentiation of photoinactivation of Gram-positive and Gram-negative bacteria mediated by six phenothiazinium dyes by addition of azide ion
  620. Clostridium difficileinfection: molecular pathogenesis and novel therapeutics
  621. Cutaneous Sporotrichosis Treated with Photodynamic Therapy: An in Vitro and in Vivo Study
  622. Conclusions and future directions
  623. Experimental methods and results for the nanoscopic lens
  624. Intense focused ultrasound
  625. Laser and light treatment for skin photoaging
  626. Low-level light therapy (LLLT)
  627. Minimal invasive treatment
  628. Conclusions
  629. Introduction
  630. Nanoscopic lens modeling
  631. Primary prevention for skin photoaging
  632. Radiofrequency technology
  633. Secondary prevention for skin photoaging
  634. Skin aging and photoaging
  635. The nanoscopic lens: new generation applications and future scope
  636. Theory of nanoparticles in the nanoscopic lens
  637. Antimicrobial Blue Light Therapy for Multidrug-Resistant Acinetobacter baumannii Infection in a Mouse Burn Model: Implications for Prophylaxis and Treatment of Combat-related Wound Infections
  638. Electroporation enhances antimicrobial photodynamic therapy mediated by the hydrophobic photosensitizer, hypericin
  639. Surface modification of a polyhedral oligomeric silsesquioxane poly(carbonate-urea) urethane (POSS-PCU) nanocomposite polymer as a stent coating for enhanced capture of endothelial progenitor cells
  640. Thiocyanate potentiates antimicrobial photodynamic therapy: In situ generation of the sulfur trioxide radical anion by singlet oxygen
  641. Preservation of Protein Dynamics in Dihydrofolate Reductase Evolution
  642. Use of optical imaging to progress novel therapeutics to the clinic
  643. Can biowarfare agents be defeated with light?
  644. Antimicrobial strategies centered around reactive oxygen species – bactericidal antibiotics, photodynamic therapy, and beyond
  645. Blue Light Eliminates Community-Acquired Methicillin-ResistantStaphylococcus aureusin Infected Mouse Skin Abrasions
  646. Effects of Photodynamic Therapy on Gram-Positive and Gram-Negative Bacterial Biofilms by Bioluminescence Imaging and Scanning Electron Microscopic Analysis
  647. Perfusion Defatting at Subnormothermic Temperatures in Steatotic Rat Livers
  648. Low-level laser therapy (810 nm) protects primary cortical neurons against excitotoxicity in vitro
  649. Real-time in vivo imaging of invasive- and biomaterial-associated bacterial infections using fluorescently labelled vancomycin
  650. Cyclic Tetrapyrroles in Photodynamic Therapy: The Chemistry of Porphyrins and Related Compounds in Medicine
  651. Synthesis of Decacationic C70 Bisadducts by Incorporating Covalently BoundElectron-Donors for Enhancement of Radical-Based Type-I PDT
  652. Disruptive innovations: new anti-infectives in the age of resistance
  653. Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond
  654. Selective photoinactivation of Candida albicans in the non-vertebrate host infection model Galleria mellonella
  655. Ultraviolet Radiation in Wound Care: Sterilization and Stimulation
  656. Photodynamic Therapy of Murine Mastocytoma Induces Specific Immune Responses against the Cancer/Testis Antigen P1A
  657. Photodynamic therapy plus regulatory T-cell depletion produces immunity against a mouse tumour that expresses a self-antigen
  658. Low-level laser therapy for spinal cord injury in rats: effects of polarization
  659. Track segments in hadronic showers in a highly granular scintillator-steel hadron calorimeter
  660. Shining light on nanotechnology to help repair and regeneration
  661. Low-level laser (light) therapy (LLLT) for treatment of hair loss
  662. 4D Multimodality Imaging of <em>Citrobacter rodentium</em> Infections in Mice
  663. Synthesis of Photoresponsive Dual NIR Two-Photon Absorptive [60]Fullerene Triads and Tetrads
  664. Linear and Nonlinear Optical Properties of Photoresponsive [60]Fullerene Hybrid Triads and Tetrads with Dual NIR Two-Photon Absorption Characteristics
  665. CpG oligodeoxynucleotide as immune adjuvant enhances photodynamic therapy response in murine metastatic breast cancer
  666. Vancomycin-Rifampin Combination Therapy Has Enhanced Efficacy against an Experimental Staphylococcus aureus Prosthetic Joint Infection
  667. Corrigendum
  668. Low level laser therapy increases angiogenesis in a model of ischemic skin flap in rats mediated by VEGF, HIF-1α and MMP-2
  669. The biochemistry of the metabolic poison propionate 3-nitronate and its conjugate acid, 3-nitropropionate
  670. Validation of GEANT4 Monte Carlo models with a highly granular scintillator-steel hadron calorimeter
  671. Antimicrobial Photodynamic Therapy to Kill Gram-negative Bacteria
  672. Photodynamic inactivation of biofilm: taking a lightly colored approach to stubborn infection
  673. UV-absorbing bacteria in coral mucus and their response to simulated temperature elevations
  674. Low-level laser therapy for fat layer reduction: A comprehensive review
  675. Channelrhodopsins: visual regeneration and neural activation by a light switch
  676. Studies on fast triggering and high precision tracking with Resistive Plate Chambers
  677. Photoinduced electron-transfer mechanisms for radical-enhanced photodynamic therapy mediated by water-soluble decacationic C70 and C84O2 Fullerene Derivatives
  678. Synthesis of decacationic [60]fullerene decaiodides giving photoinduced production of superoxide radicals and effective PDT-mediation on antimicrobial photoinactivation
  679. Synthesis, bioanalysis and biodistribution of photosensitizer conjugates for photodynamic therapy
  680. Effect of red and near-infrared wavelengths on low-level laser (light) therapy-induced healing of partial-thickness dermal abrasion in mice
  681. The novel albumin–chitosan core–shell nanoparticles for gene delivery: preparation, optimization and cell uptake investigation
  682. Decacationic [70]Fullerene Approach for Efficient Photokilling of Infectious Bacteria and Cancer Cells
  683. Low-level laser therapy can produce increased aggressiveness of dysplastic and oral cancer cell lines by modulation of Akt/mTOR signaling pathway
  684. Microbial Efflux Systems and Inhibitors: Approaches to Drug Discovery and the Challenge of Clinical Implementation
  685. Transcranial low-level light therapy produces neuroprotection, neurogenesis and BDNF after TBI in mice
  686. Enhanced detection of myeloperoxidase activity in deep tissues through luminescent excitation of near-infrared nanoparticles
  687. Photodynamic therapy stimulates anti-tumor immune response in mouse models: the role of regulatory Tcells, anti-tumor antibodies, and immune attacks on brain metastases
  688. Linezolid and Vancomycin Decrease the Therapeutic Effect of Methylene Blue-Photodynamic therapy in a Mouse Model of MRSA Bacterial Arthritis
  689. Photodynamic and Antibiotic Therapy Impair the Pathogenesis of Enterococcus faecium in a Whole Animal Insect Model
  690. Photochemical activation of TRPA1 channels in neurons and animals
  691. Molecular Electronic Tuning of Photosensitizers to Enhance Photodynamic Therapy: Synthetic Dicyanobacteriochlorins as a Case Study
  692. Effect of Virulence Factors on the Photodynamic Inactivation of Cryptococcus neoformans
  693. Animal models of skin disease for drug discovery
  694. Melanoma resistance to photodynamic therapy: new insights
  695. Transcranial Low-Level Laser Therapy Improves Neurological Performance in Traumatic Brain Injury in Mice: Effect of Treatment Repetition Regimen
  696. Can osteoarthritis be treated with light?
  697. Self-assembled liposomal nanoparticles in photodynamic therapy
  698. Synthesis and evaluation of cationic bacteriochlorin amphiphiles with effective in vitro photodynamic activity against cancer cells at low nanomolar concentration
  699. Low-level laser therapy (LLLT) reduces oxidative stress in primary cortical neurons in vitro
  700. Blue Light Rescues Mice from Potentially Fatal Pseudomonas aeruginosa Burn Infection: Efficacy, Safety, and Mechanism of Action
  701. Paradoxical potentiation of methylene blue-mediated antimicrobial photodynamic inactivation by sodium azide: Role of ambient oxygen and azide radicals
  702. Low-level laser therapy (LLLT) combined with swimming training improved the lipid profile in rats fed with high-fat diet
  703. Antimicrobial Photodynamic Inactivation Inhibits Candida albicans Virulence Factors and ReducesIn VivoPathogenicity
  704. Bioluminescent Bacterial Imaging <em>In Vivo</em>
  705. Pre-treatment with Bifidobacterium breve UCC2003 modulates Citrobacter rodentium-induced colonic inflammation and organ specificity
  706. Monitoring Bacterial Burden, Inflammation and Bone Damage Longitudinally Using Optical and μCT Imaging in an Orthopaedic Implant Infection in Mice
  707. Killing Bacterial Spores with Blue Light: When Innate Resistance Meets the Power of Light
  708. Stable Synthetic Bacteriochlorins for Photodynamic Therapy: Role of Dicyano Peripheral Groups, Central Metal Substitution (2H, Zn, Pd), and Cremophor EL Delivery
  709. Improved Language after Scalp Application of Red/Near-Infrared Light-Emitting Diodes: Pilot Study supporting a New, Noninvasive Treatment for Chronic Aphasia
  710. Hadronic energy resolution of a highly granular scintillator-steel hadron calorimeter using software compensation techniques
  711. Low-level laser therapy (808 nm) reduces inflammatory response and oxidative stress in rat tibialis anterior muscle after cryolesion
  712. Bacterial vectors for imaging and cancer gene therapy: a review
  713. Antimicrobial photodynamic therapy with RLP068 kills methicillin-resistantStaphylococcus aureusand improves wound healing in a mouse model of infected skin abrasion PDT with RLP068/Cl in infected mouse skin abrasion
  714. Cellular and vascular effects of the photodynamic agent temocene are modulated by the delivery vehicle
  715. Ultraviolet C light for Acinetobacter baumannii wound infections in mice
  716. Photodynamic Therapy for Cancer and for Infections: What Is the Difference?
  717. Low-level laser therapy (808 nm) contributes to muscle regeneration and prevents fibrosis in rat tibialis anterior muscle after cryolesion
  718. Acute and Impaired Wound Healing
  719. Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond?
  720. Chitosan dressing promotes healing in third degree burns in mice: Gene expression analysis shows biphasic effects for rapid tissue regeneration and decreased fibrotic signaling
  721. Transcranial low level laser (light) therapy for traumatic brain injury
  722. Characterization of a Conjugate between Rose Bengal and Chitosan for Targeted Antibiofilm and Tissue Stabilization Effects as a Potential Treatment of Infected Dentin
  723. Type I and Type II mechanisms of antimicrobial photodynamic therapy: An in vitro study on gram-negative and gram-positive bacteria
  724. Acute and Impaired Wound Healing
  725. Photodynamic therapy induces an immune response against a bacterial pathogen
  726. Shivajiella indica gen. nov., sp. nov., a marine bacterium of the family “Cyclobacteriaceae” with nitrate reducing activity
  727. Surface layer-preserving photodynamic therapy (SPPDT) in a subcutaneous mouse model of lung cancer
  728. Photodynamic Therapy Can Induce a Protective Innate Immune Response against Murine Bacterial Arthritis via Neutrophil Accumulation
  729. UVC Light Prophylaxis for Cutaneous Wound Infections in Mice
  730. Synthesis and Characterization of Positively Charged Pentacationic [60]Fullerene Monoadducts for Antimicrobial Photodynamic Inactivation
  731. A novel activity for fungal nitronate monooxygenase: Detoxification of the metabolic inhibitor propionate-3-nitronate
  732. Construction and performance of a silicon photomultiplier/extruded scintillator tail-catcher and muon-tracker
  733. Synthesis and Photodynamic Effect of New Highly Photostable Decacationically Armed [60]- and [70]Fullerene Decaiodide Monoadducts To Target Pathogenic Bacteria and Cancer Cells
  734. Antimicrobial Photodynamic Therapy and Photodynamic Inactivation, or Killing Bugs with Dyes and Light-A Symposium-in-Print
  735. In Vivo Optical Imaging in Gene & Cell Therapy
  736. Abstract 382: In-vivo imaging of lung cancer using tumor homing peptide coated nanoparticles
  737. Low level laser therapy reduces oxidative stress in cortical neurons in vitro
  738. Effects of polarization in low-level laser therapy of spinal cord injury in rats
  739. In vivo studies of low level laser (light) therapy for traumatic brain injury
  740. Photodynamic therapy with hyperbranched poly(ether-ester) chlorin(e6) nanoparticles on human tongue carcinoma CAL-27 cells
  741. Can nanotechnology potentiate photodynamic therapy?
  742. Glutathione Reductase Facilitates Host Defense by Sustaining Phagocytic Oxidative Burst and Promoting the Development of Neutrophil Extracellular Traps
  743. Daptomycin and Tigecycline Have Broader Effective Dose Ranges than Vancomycin as Prophylaxis against a Staphylococcus aureus Surgical Implant Infection in Mice
  744. Human Platelet-Rich Plasma- and Extracellular Matrix-Derived Peptides Promote Impaired Cutaneous Wound Healing In Vivo
  745. Strategies to Potentiate Antimicrobial Photoinactivation by Overcoming Resistant Phenotypes†
  746. Wound‐Healing Properties of Chitosan and Its Use in Wound Dressing Biopharmaceuticals
  747. Photodynamic therapy can induce non-specific protective immunity against a bacterial infection
  748. Ultraviolet C irradiation: an alternative antimicrobial approach to localized infections?
  749. High Resolution In Vivo Bioluminescent Imaging for the Study of Bacterial Tumour Targeting
  750. Low-Level Laser Therapy for Closed-Head Traumatic Brain Injury in Mice: Effect of Different Wavelengths
  751. A renaissance in low-level laser (light) therapy – LLLT
  752. Concepts and Principles of Photodynamic Therapy as an Alternative Antifungal Discovery Platform
  753. Far infrared radiation (FIR): Its biological effects and medical applications
  754. Gram-Negative Bacterial Infection in Thigh Abscess Can Migrate to Distant Burn Depending on Burn Depth
  755. Low intensity laser therapy accelerates muscle regeneration in aged rats
  756. Low-level laser (light) therapy (LLLT) on muscle tissue: performance, fatigue and repair benefited by the power of light
  757. Multi-Functionality in Theranostic Nanoparticles: is more Always Better?
  758. Intraperitoneal photodynamic therapy mediated by a fullerene in a mouse model of abdominal dissemination of colon adenocarcinoma
  759. Photodynamic therapy with fullerenes in vivo: reality or a dream?
  760. Beam tests of directly coupled scintillator tiles with MPPC readout
  761. The Nuts and Bolts of Low-level Laser (Light) Therapy
  762. All you need is light
  763. Optimal Photosensitizers for Photodynamic Therapy of Infections Should Kill Bacteria but Spare Neutrophils
  764. Down‐regulation of glutatione S‐transferase α 4 (hGSTA4) in the muscle of thermally injured patients is indicative of susceptibility to bacterial infection
  765. Photodynamic Therapy: Photosensitizer Targeting and Delivery
  766. Comparison of Therapeutic Effects between Pulsed and Continuous Wave 810-nm Wavelength Laser Irradiation for Traumatic Brain Injury in Mice
  767. Long-term monitoring of live cell proliferation in presence of PVP-Hypericin: a new strategy using ms pulses of LED and the fluorescent dye CFSE
  768. Effects of high-energy particle showers on the embedded front-end electronics of an electromagnetic calorimeter for a future lepton collider
  769. Production and commissioning of a large prototype Digital Hadron Calorimeter for future colliding beam experiments
  770. Imaging Pulmonary NF-kappaB Activation and Therapeutic Effects of MLN120B and TDZD-8
  771. Blue Dye and Red Light, a Dynamic Combination for Prophylaxis and Treatment of Cutaneous Candida albicans Infections in Mice
  772. Biphasic Dose Response in Low Level Light Therapy – an Update
  773. Dose response effects of 810 nm laser light on mouse primary cortical neurons
  774. Photodynamic therapy for infections: Clinical applications
  775. Mouse model of chronic post-arthroplasty infection: Noninvasive in vivo bioluminescence imaging to monitor bacterial burden for long-term study
  776. Low-Level Laser Therapy Activates NF-kB via Generation of Reactive Oxygen Species in Mouse Embryonic Fibroblasts
  777. Tests of a Particle Flow Algorithm with CALICE test beam data
  778. Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects
  779. Potential for Transcranial Laser or LED Therapy to Treat Stroke, Traumatic Brain Injury, and Neurodegenerative Disease
  780. Reply to “Championing photoantimicrobial discovery”
  781. Animal models of external traumatic wound infections
  782. Low Level Laser and Light Therapy
  783. Cell Death Pathways in Photodynamic Therapy of Cancer
  784. Effects of 810-nm Laser on Murine Bone-Marrow-Derived Dendritic Cells
  785. Antimicrobial photodynamic therapy: Can resistance develop?
  786. Photodynamic therapy of cancer: An update
  787. Combination approaches to potentiate immune response after photodynamic therapy for cancer
  788. The immunosuppressive side of PDT
  789. Drug Discovery of Antimicrobial Photosensitizers Using Animal Models
  790. Improved Cognitive Function After Transcranial, Light-Emitting Diode Treatments in Chronic, Traumatic Brain Injury: Two Case Reports
  791. Influence of multidrug efflux systems on methylene blue-mediated photodynamic inactivation of Candida albicans
  792. Synergistic Combination of Chitosan Acetate with Nanoparticle Silver as a Topical Antimicrobial: Efficacy against Bacterial Burn Infections
  793. Antimicrobial Photodynamic Therapy in the Colon: Delivering a Light Punch to the Guts?
  794. Antimicrobial and Efflux Pump Inhibitory Activity of Caffeoylquinic Acids from Artemisia absinthium against Gram-Positive Pathogenic Bacteria
  795. Electromagnetic response of a highly granular hadronic calorimeter
  796. Antimicrobial mechanisms behind photodynamic effect in the presence of hydrogen peroxide
  797. Photodynamic inactivation of bacteria using polyethylenimine-chlorin(e6) conjugates: Effect of polymer molecular weight, substitution ratio of chlorin(e6) and pH
  798. Protective role of IL-1β against post-arthroplasty Staphylococcus aureus infection
  799. Photodynamic therapy using intra-articular photofrin for murine MRSA arthritis: Biphasic light dose response for neutrophil-mediated antibacterial effect
  800. Analysis of the Bacterial Heat Shock Response to Photodynamic Therapy-mediated Oxidative Stress
  801. Effects of 810 nm laser on mouse primary cortical neurons
  802. Oxidative stress of photodynamic antimicrobial chemotherapy inhibits Candida albicans virulence
  803. The potential role of functional inhibition of T regulatory cells by anti-TGFβ antibody in photodynamic therapy of renal cancer
  804. Ultraviolet-C Light for Treatment of Candida albicans Burn Infection in Mice
  805. Cryptococcus neoformans capsule protects cell from oxygen reactive species generated by antimicrobial photodynamic inactivation
  806. American Society for Laser Medicine and Surgery Abstracts
  807. Working model of an atomic force microscope
  808. Photodynamic Inactivation of Microbial Pathogens
  809. Antimicrobial Photodynamic Therapy with Functionalized Fullerenes: Quantitative Structure-activity Relationships
  810. Stimulation of anti-tumor immunity by photodynamic therapy
  811. Contents
  812. Dedication
  813. Front Matter
  814. Subject Index
  815. Volume Preface
  816. Therapeutic applications of light: PDT - the killer; LLLT - the healer
  817. Visualization of plant viral suppressor silencing activity in intact leaf lamina by quantitative fluorescent imaging
  818. Photodynamic Therapy of Tumors Can Lead to Development of Systemic Antigen-Specific Immune Response
  819. Photodynamic therapy with a cationic functionalized fullerene rescues mice from fatal wound infections
  820. Role of Low‐Level Laser Therapy in Neurorehabilitation
  821. In vivo sodium concentration continuously monitored with fluorescent sensors
  822. Ultraviolet-C Irradiation for Prevention of Central Venous Catheter-related Infections: An In Vitro Study
  823. FACTORS AFFECTING THE INCIDENCE OF 'RUSSET BROWNING' DISORDER IN 'COX'S ORANGE PIPPIN' APPLES
  824. Cationic Porphycenes as Potential Photosensitizers for Antimicrobial Photodynamic Therapy
  825. Efflux Pump Inhibitor Potentiates Antimicrobial Photodynamic Inactivation of Enterococcus faecalis Biofilm
  826. Corrigendum: Pentalysine β-Carbonylphthalocyanine Zinc: An Effective Tumor-Targeting Photosensitizer for Photodynamic Therapy
  827. The risk of biomaterial-associated infection after revision surgery due to an experimental primary implant infection
  828. Effect of pulsing in low-level light therapy
  829. Introduction to experimental and clinical studies using low-level Laser (light) therapy (LLLT)
  830. Stable Synthetic Cationic Bacteriochlorins as Selective Antimicrobial Photosensitizers
  831. Photodynamic inactivation of Acinetobacter baumannii using phenothiazinium dyes: In vitro and in vivo studies
  832. Topical Antimicrobials for Burn Wound Infections
  833. Can surgical site infections be treated by photodynamic therapy?
  834. Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials
  835. Evaluating the surface density and heterogeneity of a dithiobis (succinimidylpropionate) self-assembled monolayer on gold and its coupling with DNA embedded within a matrix
  836. In Vitro Photodynamic Therapy and Quantitative Structure−Activity Relationship Studies with Stable Synthetic Near-Infrared-Absorbing Bacteriochlorin Photosensitizers
  837. Study of the interactions of pions in the CALICE silicon-tungsten calorimeter prototype
  838. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation
  839. The shortage of medical oncologists and low chemotherapy utilization in Australia.
  840. Advances in Low-Intensity Laser and Phototherapy
  841. Low-Level Laser Therapy in Stroke and Central Nervous System
  842. Pentalysine β-Carbonylphthalocyanine Zinc: An Effective Tumor-Targeting Photosensitizer for Photodynamic Therapy
  843. Construction and commissioning of the CALICE analog hadron calorimeter prototype
  844. Amorphous Basophilic Deposit in the Superficial Dermis of the Lip in an 80 Year Old
  845. Stable synthetic bacteriochlorins overcome the resistance of melanoma to photodynamic therapy
  846. Protective effects of Red/Near Infrared Radiation on Murine Cardiac Ischemia/Reperfusion Injury
  847. Fluorescent Nano-Optodes for Glucose Detection
  848. Low level laser therapy for traumatic brain injury
  849. Can dendritic cells see light?
  850. Comparison of cellular responses induced by low level light in different cell types
  851. Front Matter for Volume 7552
  852. Photodynamic therapy for cancer and activation of immune response
  853. Transcranial LED therapy for cognitive dysfunction in chronic, mild traumatic brain injury: two case reports
  854. Book Review
  855. Characterization of Plant-Derived Saponin Natural Products against Candida albicans
  856. Synthesis and characterization of highly photoresponsive fullerenyl dyads with a close chromophore antenna–C60 contact and effective photodynamic potential
  857. Antimicrobial Photodynamic Inactivation and Photodynamic Therapy for Infections
  858. Dye-enhanced multimodal confocal microscopy for noninvasive detection of skin cancers in mouse models
  859. Photodynamic therapy for methicillin-resistant Staphylococcus aureus infection in a mouse skin abrasion model
  860. Nitronate monooxygenase, a model for anionic flavin semiquinone intermediates in oxidative catalysis
  861. Kinetic evidence for an anion binding pocket in the active site of nitronate monooxygenase
  862. Imidazole metalloporphyrins as photosensitizers for photodynamic therapy: Role of molecular charge, central metal and hydroxyl radical production
  863. Measuring prions by bioluminescence imaging
  864. Biphasic Dose Response in Low Level Light Therapy
  865. Photodynamic therapy for localized infections—State of the art
  866. Response of the CALICE Si-W electromagnetic calorimeter physics prototype to electrons
  867. Directly coupled tiles as elements of a scintillator calorimeter with MPPC readout
  868. Photodynamic Therapy for Acinetobacter baumannii Burn Infections in Mice
  869. Influence of bacterial interactions on the susceptibility to photodynamic inactivation
  870. Anti-tumor immune response after photodynamic therapy
  871. Antimicrobial photodynamic therapy in a mouse model of Acinetobacter baumannii burn infection
  872. Combination of PDT and a DNA demethylating agent produces anti-tumor immune response in a mouse tumor model
  873. New stable synthetic bacteriochlorins for photodynamic therapy of melanoma
  874. Treatment of Helicobacter pylori infection with intra-gastric violet light phototherapy: A pilot clinical trial
  875. Uptake pathways of anionic and cationic photosensitizers into bacteria
  876. Proteasome Inhibition Potentiates Antitumor Effects of Photodynamic Therapy in Mice through Induction of Endoplasmic Reticulum Stress and Unfolded Protein Response
  877. Review of Dessalles (): Why We Talk: The Evolutionary Origins of Language
  878. Role of ROS-mediated TGF beta activation in laser photobiomodulation
  879. Role of reactive oxygen species in low level light therapy
  880. Low level laser therapy activates NF-kB via generation of reactive oxygen species in mouse embryonic fibroblasts
  881. Stimulation of dendritic cells enhances immune response after photodynamic therapy
  882. Inflated Kinetic Isotope Effects in the Branched Mechanism of Neurospora crassa 2-Nitropropane Dioxygenase
  883. Photodynamic Therapy
  884. Paralanguage
  885. Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety
  886. Real time noninvasive monitoring of contaminating bacteria in a soft tissue implant infection model
  887. Transient Filling of Sacrificially Etched Nanochannels by Capillarity
  888. Photophysical characterization of imidazolium-substituted Pd(II), In(III), and Zn(II) porphyrins as photosensitizers for photodynamic therapy
  889. Chitosan Acetate Bandage as a Topical Antimicrobial Dressing for Infected Burns
  890. Alemtuzumab Administered by Subcutaneous Route Is Less Effective Than Intravenous Route for First Line Therapy of T-Cell Prolymphocytic Leukaemia: Results of a Pilot Study (UKCLL05)
  891. Adverse drug reactions to treatments for ocular toxoplasmosis: A retrospective chart review
  892. Glypican-3 as a Useful Diagnostic Marker That Distinguishes Hepatocellular Carcinoma From Benign Hepatocellular Mass Lesions
  893. Distinctive Features of Foreskin Condylomata Acuminata Associated with Diabetes Mellitus
  894. The Nonoxidative Conversion of Nitroethane to Ethylnitronate in Neurospora crassa 2-Nitropropane Dioxygenase Is Catalyzed by Histidine 196
  895. Design and electronics commissioning of the physics prototype of a Si-W electromagnetic calorimeter for the International Linear Collider
  896. Value of Glypican 3 Immunostaining in the Diagnosis of Hepatocellular Carcinoma on Needle Biopsy
  897. Ultraviolet C inactivation of dermatophytes: implications for treatment of onychomycosis
  898. MAPMT H7546B Anode Current Response Study for an ILC SiD Muon System Prototype
  899. Inhibitors of Bacterial Multidrug Efflux Pumps Potentiate Antimicrobial Photoinactivation
  900. Triplet and ground state potential energy surfaces of 1,4-diphenyl-1,3-butadiene: theory and experiment
  901. Effect of chitosan acetate bandage on wound healing in infected and noninfected wounds in mice
  902. Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model
  903. Atrial Thrombosis: A near Fatal Complication of a Portacath
  904. Antimicrobial comparison on effectiveness of endodontic therapy and endodontic therapy combined with photo-disinfection on patients with periapical lesion: a 6 month follow-up
  905. The role of nitric oxide in low level light therapy
  906. Photodynamic therapy stimulates anti-tumor immunity in a murine mastocytoma model
  907. Antimicrobial Effects of Photodynamic Therapy on Patients with Necrotic Pulps and Periapical Lesion
  908. Intravascular detection of inflamed atherosclerotic plaques using a fluorescent photosensitizer targeted to the scavenger receptor
  909. “MeaningNN” and “showing”: Gricean intentions and relevance-theoretic intentions
  910. Combination Immunotherapy and Photodynamic Therapy for Cancer
  911. Involvement of Skeletal Muscle Gene Regulatory Network in Susceptibility to Wound Infection Following Trauma
  912. Photodynamic therapy with fullerenes
  913. Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism
  914. Susceptibility of Cryptococcus neoformans to Photodynamic Inactivation Is Associated with Cell Wall Integrity
  915. Burn Injury Reveals Altered Phenotype in Mannan-Binding Lectin-Deficient Mice
  916. The susceptibility of kiwifruit to low temperature breakdown is associated with pre-harvest temperatures and at-harvest soluble solids content
  917. Cellular chromophores and signaling in low level light therapy
  918. Low-level light therapy for zymosan-induced arthritis in rats
  919. Photodynamic therapy stimulates anti-tumor immunity in a murine model
  920. A comparative in vitro photoinactivation study of clinical isolates of multidrug-resistant pathogens
  921. Antimicrobial photodynamic therapy combined with conventional endodontic treatment to eliminate root canal biofilm infection
  922. Low-level laser therapy for zymosan-induced arthritis in rats: Importance of illumination time
  923. Low-level light stimulates excisional wound healing in mice
  924. Photonic real-time monitoring of bacterial reduction in root canals by genetically engineered bacteria after chemomechanical endodontic therapy
  925. Synthesis and Properties of Benzo[a]phenoxazinium Chalcogen Analogues as Novel Broad-Spectrum Antimicrobial Photosensitizers.
  926. Studies of silicon photodetectors for scintillator-based Hadron Calorimetry at the International Linear Collider
  927. Probing the Chemical Steps of Nitroalkane Oxidation Catalyzed by 2-Nitropropane Dioxygenase with Solvent Viscosity, pH, and Substrate Kinetic Isotope Effects
  928. Relevance and prosody
  929. Macrophage-Targeted Photosensitizer Conjugate Delivered by Intratumoral Injection
  930. Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice
  931. Synthesis and Properties of Benzo[a]phenoxazinium Chalcogen Analogues as Novel Broad-Spectrum Antimicrobial Photosensitizers
  932. Photodynamic therapy and anti-tumour immunity
  933. Primary Peritoneal Epithelioid Hemangioendothelioma
  934. Bioconjugatable Porphyrins Bearing a Compact Swallowtail Motif for Water Solubility
  935. Protease-Stable Polycationic Photosensitizer Conjugates between Polyethyleneimine and Chlorin(e6) for Broad-Spectrum Antimicrobial Photoinactivation
  936. Behavioral Health in Multiracial Adolescents: The Role of Hispanic/Latino Ethnicity
  937. Mechanisms of low level light therapy
  938. Wound healing stimulation in mice by low-level light
  939. Combination immunotherapy and photodynamic therapy for cancer
  940. Dye-enhanced reflectance and fluorescence confocal microscopy as an optical pathology tool
  941. Enhancing photodynamic therapy of a metastatic mouse breast cancer by immune stimulation
  942. Deficiency of Mannose-Binding Lectin Greatly Increases Susceptibility to Postburn Infection with Pseudomonas aeruginosa
  943. Expression of firefly luciferase in Candida albicans and its use in the selection of stable transformants
  944. Visualizing fungal infections in living mice using bioluminescent pathogenic Candida albicans strains transformed with the firefly luciferase gene
  945. A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy
  946. Phenothiazinium Antimicrobial Photosensitizers Are Substrates of Bacterial Multidrug Resistance Pumps
  947. Photosensitizer delivery to vulnerable atherosclerotic plaque: comparison of macrophage-targeted conjugate versus free chlorine(e6)
  948. Photodynamic Inactivation of Bacillus Spores, Mediated by Phenothiazinium Dyes
  949. Human Osteoblast Precursors Produce Extracellular Adenosine, Which Modulates Their Secretion of IL-6 and Osteoprotegerin
  950. Cationic Fullerenes Are Effective and Selective Antimicrobial Photosensitizers
  951. Monitoring photodynamic therapy of localized infections by bioluminescence imaging of genetically engineered bacteria
  952. Greater propensity of diabetic myocardium for oxidative stress after myocardial infarction is associated with the development of heart failure
  953. Photodynamic therapy for Staphylococcus aureus infected burn wounds in mice
  954. Helicobacter pylori Accumulates Photoactive Porphyrins and Is Killed by Visible Light
  955. Noninvasive Biophotonic Imaging for Monitoring of Catheter-Associated Urinary Tract Infections and Therapy in Mice
  956. Macrophage-Targeted Photodynamic Therapy: Scavenger Receptor Expression and Activation State
  957. Autism interventions: a critical update
  958. Effect of Cell-Photosensitizer Binding and Cell Density on Microbial Photoinactivation
  959. Mechanisms in photodynamic therapy: Part three—Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction
  960. Investigation of a solid-state photodetector
  961. Anti-tumor immunity generated by photodynamic therapy in a metastatic murine tumor model
  962. Anthrax surrogate spores are destroyed by PDT mediated by phenothiazinium dyes
  963. Monitoring in vivo fitness of rifampicin-resistant Staphylococcus aureus mutants in a mouse biofilm infection model
  964. Mechanisms in photodynamic therapy: part two—cellular signaling, cell metabolism and modes of cell death
  965. An Analysis of Genetic Diversity Across the Maize Genome Using Microsatellites
  966. Involvement of a Flavosemiquinone in the Enzymatic Oxidation of Nitroalkanes Catalyzed by 2-Nitropropane Dioxygenase
  967. Real-Time In Vivo Bioluminescent Imaging for Evaluating the Efficacy of Antibiotics in a Rat Staphylococcus aureus Endocarditis Model
  968. Helicobacter pylori in patients can be killed by visible light
  969. Molecular Delivery into a Lipid Bilayer with a Single Shock Waves Using Molecular Dynamic Simulation
  970. Experience with Laparoscopic Adjustable Gastric Banding (La-Band System) up to 8 Years
  971. Mechanisms in photodynamic therapy: part one—photosensitizers, photochemistry and cellular localization
  972. Tissue‐Specific Contributions of Pneumococcal Virulence Factors to Pathogenesis
  973. Healing of perforating rat corneal incisions closed with photodynamic laser-activated tissue glue
  974. Photodynamic Therapy Targeted to Pathogens
  975. Small scintillating cells as the active elements in a digital hadron calorimeter for the e+e linear collider detector
  976. Toward a scintillator based digital hadron calorimeter for the linear collider detector
  977. Photodynamic therapy cures green fluorescent protein expressing RIF1 tumors in mice
  978. Targeted photodynamic therapy of established soft-tissue infections in mice
  979. Effects of Growth Phase and Extracellular Slime on Photodynamic Inactivation of Gram-Positive Pathogenic Bacteria
  980. Noninvasive Optical Imaging Method To Evaluate Postantibiotic Effects on Biofilm Infection In Vivo
  981. Mannose-binding Lectin-deficient Mice Are Susceptible to Infection with Staphylococcus aureus
  982. Photodynamic therapy: a new antimicrobial approach to infectious disease?
  983. Targeted photodynamic therapy of established soft-tissue infections in mice
  984. Macrophage-Targeted Photodynamic Therapy
  985. Extracellular Replication of Listeria monocytogenes in the Murine Gall Bladder
  986. Hamstring anterior cruciate ligament reconstruction: a comparison of bioabsorbable interference screw and endobutton-post fixation
  987. The Possible Prognostic Significance of Immunophenotype in Feline Alimentary Lymphoma: a Pilot Study
  988. Estrogen Depletion Differentially Affects Blood Pressure Depending on Age in Long–Evans Rats
  989. Spectroscopic and Kinetic Properties of Recombinant Choline Oxidase from Arthrobacter globiformis
  990. The AGUAAA motif in cspA1/A2 mRNA is important for adaptation of Yersinia enterocolitica to grow at low temperature
  991. Natural Pragmatics and Natural Codes

Showing 1,000 Stories.